Stockreport

Madrigal Pharmaceuticals: My Take On Prospects For 2026 Leads To Rating Downgrade [Seeking Alpha]

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com
PDF Despite robust sales, MDGL remains unprofitable and faces intensifying competition from GLP-1 drugs and emerging FGF21 inhibitors targeting the same market. Managemen [Read more]